UBS Group’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-5,188
| Closed | -$11K | – | 10040 |
|
|
2021
Q3 | $11K | Sell |
5,188
-21,261
| -80% | -$45.1K | ﹤0.01% | 6824 |
|
|
2021
Q2 | $79K | Buy |
26,449
+10,243
| +63% | +$30.6K | ﹤0.01% | 5018 |
|
|
2021
Q1 | $45K | Sell |
16,206
-3,094
| -16% | -$8.59K | ﹤0.01% | 5664 |
|
|
2020
Q4 | $46K | Buy |
19,300
+14,590
| +310% | +$34.8K | ﹤0.01% | 5278 |
|
|
2020
Q3 | $10K | Sell |
4,710
-11,778
| -71% | -$25K | ﹤0.01% | 6013 |
|
|
2020
Q2 | $63K | Sell |
16,488
-8,553
| -34% | -$32.7K | ﹤0.01% | 4853 |
|
|
2020
Q1 | $47K | Sell |
25,041
-23,986
| -49% | -$45K | ﹤0.01% | 5004 |
|
|
2019
Q4 | $102K | Buy |
49,027
+24,486
| +100% | +$50.9K | ﹤0.01% | 4970 |
|
|
2019
Q3 | $59K | Buy |
24,541
+20,841
| +563% | +$50.1K | ﹤0.01% | 5172 |
|
|
2019
Q2 | $12K | Sell |
3,700
-503
| -12% | -$1.63K | ﹤0.01% | 6101 |
|
|
2019
Q1 | $21K | Buy |
4,203
+1,858
| +79% | +$9.28K | ﹤0.01% | 5462 |
|
|
2018
Q4 | $11K | Buy |
2,345
+1,896
| +422% | +$8.89K | ﹤0.01% | 6283 |
|
|
2018
Q3 | $2K | Buy |
+449
| New | +$2K | ﹤0.01% | 6848 |
|
|
2018
Q1 | – | Sell |
-264
| Closed | -$2K | – | 7169 |
|
|
2017
Q4 | $2K | Sell |
264
-2,576
| -91% | -$19.5K | ﹤0.01% | 6672 |
|
|
2017
Q3 | $20K | Buy |
+2,840
| New | +$20K | ﹤0.01% | 5564 |
|
|
2016
Q4 | – | Sell |
-751
| Closed | -$4K | – | 6982 |
|
|
2016
Q3 | $4K | Sell |
751
-1,326
| -64% | -$7.06K | ﹤0.01% | 6289 |
|
|
2016
Q2 | $8K | Sell |
2,077
-892
| -30% | -$3.44K | ﹤0.01% | 6023 |
|
|
2016
Q1 | $14K | Buy |
2,969
+46
| +2% | +$217 | ﹤0.01% | 5619 |
|
|
2015
Q4 | $22K | Buy |
+2,923
| New | +$22K | ﹤0.01% | 5496 |
|